Stick With Abbott Laboratories (ABT). The Bull Are Alive And Well
BlackRock Fund Advisors recently announced the acquisition of new stake in Abbott Laboratories (NYSE:ABT). The institutional investor has increased its shareholding in the Healthcare company by 1.96% to 89.35 million shares with purchase of 1.72 million shares. This fresh investment now brings its stake to 5.15% valued currently at $9.32 billion. In addition, Capital Research […]
